CIM Investment Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,330
Closed -$629K 337
2019
Q3
$629K Sell
6,330
-2,121
-25% -$202K 0.23% 86
2019
Q2
$781K Buy
8,451
+321
+4% +$30.5K 0.29% 70
2019
Q1
$767K Sell
8,130
-4,004
-33% -$350K 0.3% 64
2018
Q4
$778K Buy
12,134
+6,778
+127% +$500K 0.34% 57
2018
Q3
$479K Sell
5,356
-2
-0% -$177 0.17% 164
2018
Q2
$426K Sell
5,358
-151
-3% -$12.5K 0.15% 193
2018
Q1
$491K Sell
5,509
-136
-2% -$13.1K 0.17% 170
2017
Q4
$589K Sell
5,645
-85
-1% -$9.59K 0.2% 136
2017
Q3
$836K Sell
5,730
-318
-5% -$43.3K 0.3% 74
2017
Q2
$785K Sell
6,048
-95
-2% -$11.6K 0.28% 82
2017
Q1
$764K Sell
6,143
-576
-9% -$68.9K 0.26% 83
2016
Q4
$778K Sell
6,719
-6,570
-49% -$732K 0.28% 85
2016
Q3
$1.39M Sell
13,289
-1,040
-7% -$113K 0.53% 29
2016
Q2
$1.41M Sell
14,329
-230
-2% -$23.8K 0.59% 31
2016
Q1
$1.46M Sell
14,559
-2,229
-13% -$230K 0.63% 29
2015
Q4
$2.01M Buy
16,788
+7,732
+85% +$895K 0.92% 20
2015
Q3
$980K Hold
9,056
0.47% 67
2015
Q2
$1.05M Buy
+9,056
New +$1.04M 0.46% 69
2014
Q4
Sell
-16,538
Closed -$1.57M 268
2014
Q3
$1.57M Sell
16,538
-914
-5% -$82.5K 0.8% 28
2014
Q2
$1.5M Sell
17,452
-494
-3% -$37.6K 0.75% 33
2014
Q1
$1.25M Sell
17,946
-494
-3% -$39.1K 0.58% 48
2013
Q4
$1.56M Buy
18,440
+1,500
+9% +$119K 0.79% 35
2013
Q3
$1.31M Hold
16,940
0.77% 43
2013
Q2
$991K Buy
+16,940
New +$1.02M 0.59% 60

Other funds holding CELG

CIM Investment Management's CELG Position: Q4 2019 in Review

CIM Investment Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,330 shares — an estimated $629K sold.

CIM Investment Management first reported a position in CELG in Q2 2013 and held it in 24 quarters. The position peaked at $2.01M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • CIM Investment Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • CIM Investment Management sold 6,330 Celgene Corp shares in Q4 2019, an estimated $629K.
  • CIM Investment Management first reported a position in Celgene Corp in Q2 2013 and held it in 24 quarters.
  • CIM Investment Management's Celgene Corp position peaked at $2.01M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on CIM Investment Management's 13F filing for Q4 2019, filed 14 Feb 2020.